Humanized Mouse and Rat Model Market Is Expected To Reach $172.83 million by 2025

According to a new market research report published by sheer analytics and insights, “Global Humanized Mouse and Rat Model market in terms of revenue is expected to reach $172.83million by 2025 at a CAGR of 9.13% from 2018 to 2025”, as per new market research report titled Global Humanized Mouse and Rat Model Market (Bymodelstype- cell-based models, and genetic models. By application- hematopoiesis, oncology, toxicology, autoimmunity, infection diseases, and others. By end-user- contract research organization, the pharmaceutical industry, and others) – global industry analysis, size, share, growth, trends, and forecast, 2017 – 2025, by Sheer Analytics & Insights Pvt. Ltd.

 In the laboratories for modeling, the human biology and diseases humanized mouse and rat models are used. They are also known by Knocking model and are used as a replacement of mouse gene by human gene or genomic sequence. It is termed as knocking as this technology consist of the deletion of a gene from the mouse genome and then it is replaced by human ortholog or gene.

Browse Full report on Global Humanized Mouse and Rat Model Market report at

In rising number of application areas for humanized mouse & rat model which includes infection diseases, oncology among others is the prime factor for the growth of this market. Investment by the key players in ensuring better healthcare facilities is one of the most influencing factors for making the market more demanding during the estimated period. Increasing occurrence of cancer diseases, surge in the production of monoclonal antibodies along with the stem cell exploration are some other factors contributing towards the growth of the humanized mouse & rat model market.

 From the past few years, the global humanized mouse and rat market is dominated by North-America. The major reasons for which the demand for humanized mouse and rat model is increasing are the growth in monoclonal antibody production, preclinical activities by CROs and pharmaceutical R&D. The market is growing also owing to the continuous and responsible use of animals which is ensured by the animal care organizations.

 Furthermore, it is estimated that the growth of the humanized mouse and rat model market will increase in Asia-Pacific owing to the international alliances for research and development activities conducted in China. In this alliance, China has taken initiatives for reducing the approval time for drugs, mandatory animal testing for every type of pharmaceutical drug along with cosmetics. The demand for this market is also increasing in India owing to the growth of the biomedical industry and the development of bio-clusters.

 While emphasizing on the importance of mice in cancer research, Charles Hewett, Jackson Lab’s former executive vice president and chief operating officer mentioned,” Mice are small, relatively speaking, they’re inexpensive to house, they’re inexpensive to feed and, best of all perhaps, they breed incredibly quickly. Jax pioneered the use of mice in genetic research and we believe very strongly in the importance of this work — work to solve the critical problems of human health and to identify and test better treatments.”

In the recent market research report that was published by Sheer Analytics & Insights, the global humanized mouse and rat model market has been segmented based on the model’s type, application, and end-user. Based on the model’s type, the market has been analyzed as cell-based models and genetic models. The cell-based models further sub-segmented into BLT model, CD34, and PBMC. The major end-user of global humanized mouse and rat model market includes contract research organization, the pharmaceutical industry, and others. Moving forward, the market is further segmented by an application such as hematopoiesis, oncology, toxicology, autoimmunity, infection diseases, and others. Geographically, global humanized mouse and rat model market segmented into North America, Middle East & Africa, Asia-Pacific, and Latin America.

List of Companies Covered:

  • Axenis S.A.S.,
  • Crown Bioscience, Inc.,
  • Champions Oncology,
  • Charles River Laboratories,
  • GenOway S.A.,
  • Harbour Antibodies BV,
  • Ingenious Targeting Laboratory, and
  • Taconic Biotechnology Co.

 By Models Type

  • Cell-based models
  • BLT model
  • CD34
  • PBMC
  • Genetic models

By Application Type

  • Hematopoiesis
  • Oncology
  • Toxicology
  • Autoimmunity
  • Infection diseases
  • Others

By End-User Type

  • Contract research organization
  • Pharmaceutical industry
  • Others

By Geography Type

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

To know more about this study, request a free sample report @

Leave a Reply

Your email address will not be published. Required fields are marked *